coumarin has been researched along with Seizures in 2 studies
2H-chromen-2-one: coumarin derivative
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Antiepileptic drugs are the mainstream treatment for epilepsy; however, the drug resistance occurring in 20-30% of patients and side effects of available medications have resulted in a search for natural remedies that can support disease therapy." | 6.61 | Coumarins as potential supportive medication for the treatment of epilepsy. ( Andres-Mach, M; Bryda, J; Szewczyk, A; Zagaja, M, 2019) |
| "Antiepileptic drugs are the mainstream treatment for epilepsy; however, the drug resistance occurring in 20-30% of patients and side effects of available medications have resulted in a search for natural remedies that can support disease therapy." | 2.61 | Coumarins as potential supportive medication for the treatment of epilepsy. ( Andres-Mach, M; Bryda, J; Szewczyk, A; Zagaja, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohammadi-Khanaposhtani, M | 1 |
| Ahangar, N | 1 |
| Sobhani, S | 1 |
| Masihi, PH | 1 |
| Shakiba, A | 1 |
| Saeedi, M | 1 |
| Akbarzadeh, T | 1 |
| Bryda, J | 1 |
| Zagaja, M | 1 |
| Szewczyk, A | 1 |
| Andres-Mach, M | 1 |
1 review available for coumarin and Seizures
| Article | Year |
|---|---|
Coumarins as potential supportive medication for the treatment of epilepsy.
Topics: Animals; Anticonvulsants; Brain; Coumarins; Disease Models, Animal; Epilepsy; Humans; Seizures | 2019 |
1 other study available for coumarin and Seizures
| Article | Year |
|---|---|
Design, synthesis, in vivo, and in silico evaluation of new coumarin-1,2,4-oxadiazole hybrids as anticonvulsant agents.
Topics: Animals; Anticonvulsants; Binding Sites; Coumarins; Drug Design; Male; Mice; Molecular Docking Simul | 2019 |